Blog creator

Zacks analyst blog highlights Textron, Northrop Grumman and L3Harris

For immediate release

Chicago, IL – July 28, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Textron Inc. TXT, Northrop Grumman Corp. NOC and L3Harris Technologies LHX.

Here are highlights from Wednesday’s analyst blog:

Second Quarter Aerospace & Defense Results Expected July 28: TXT, NOC and LHX

So far, two S&P 500 companies in the aerospace sector have released their quarterly results in the ongoing earnings cycle, namely Lockheed Martin and Raytheon Technologies. Impressively, both achieved a profit figure above expectations. Another cohort of major aerospace and defense stocks like textron inc., Northrop Grumman Corp. and L3Harris Technologies are expected to announce their earnings on July 28.

Factors Influencing Aerospace & Defense Stocks

The continued recovery in global air travel, both domestic and international, in recent quarters is expected to boost second-quarter results for aerospace and defense stocks, particularly those engaged in commercial aviation. Clearly, Boeing saw a solid 53.2% year-over-year increase in commercial shipments during the second quarter. With Boeing being the nation’s largest jet maker, we expect second-quarter results from other aerospace majors to reflect a similar improvement in delivery trends. These strong deliveries should have boosted the overall revenue growth of the Aerospace sector, which houses all aerospace and defense inventory.

On the other hand, stocks in this industry that are more combat-oriented must have won due to the constant support from the government. Additionally, steady order flow seen over the past two quarters, along with improving shipments of late, supported by the recovery in economic trends, should have supported second-quarter earnings for aerospace stocks and of the defense.

However, continued headwinds like supply chain disruption as well as some unfavorable project schedules due to the coronavirus could negatively impact the overall second quarter results of some of the industry majors.

Q2 forecast

Second-quarter aerospace profits are expected to decline 7.9% from the year-ago quarter figure, while revenues are expected to edge up 0.4%.

For more details on the quarterly releases, you can browse the latest Revenue overview.

Aerospace & Defense Stocks to Watch

Let’s take a look at three defense companies due to release their second quarter 2022 results on July 28 and find out how things fared ahead of the announcements.

textronQ2 results are expected to reflect mixed segment performance. In particular, strong deliveries of Citation aircraft and commercial turboprops as well as higher spare parts volume are expected to have boosted results in its aerospace segment, while lower military volumes may have hurt the performance of the Bell unit.

Higher commercial deliveries, favorable pricing and increased operating leverage should have bolstered its bottom line in the soon-to-be-released quarter (read more: Will mixed segment performance help Textron’s second quarter earnings?).

According to the Zacks model, the combination of a positive effect ESP Earnings and a Zacks rank of #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of beating earnings. You can see the full list of today’s Zacks #1 Rank stocks here.

Textron has an ESP on earnings of -0.38% and a #3 Zacks rating. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP Filter.

Textron Inc. Price and EPS Surprise

Textron Inc. price-eps-surprise | Submission by Textron Inc.

NorthropIts second-quarter results are expected to reflect moderate growth in the majority of its segment’s sales. While lower manned aircraft and autonomous systems volumes may have contributed unfavorably to the Aerospace segment’s revenue performance, higher volumes in the international armaments program are expected to have contributed favorably to Defense Systems’ revenues in the second quarter. .

Meanwhile, Northrop’s second-quarter earnings may have been negatively impacted by lower FAS/CAS net repo, marketable securities performance and lackluster revenue in the soon-to-be-released quarter.

Northrop has an ESP on Earnings of 0.00% and a Zacks Rank #3 (read more: Will Soft Segmented Sales Hurt Northrop’s Q2 Earnings?).

Price from Northrop Grumman Corporation and surprise EPS

Northrop Grumman Corporation price-eps-surprise | Quote from Northrop Grumman Corporation

L3Harris TechnologiesQ2 results are likely to reflect mixed sales performance across its segments. Improved commercial air traffic and higher electro-optical program volumes are expected to have boosted Integrated Mission Systems revenues, while supply chain constraints may have held back performance in the Communication Systems segment .

Factors such as flight schedule transitions, award timelines and supply chain constraints will impact quarterly business performance.

L3Harris Technologies has a +0.95% Earnings ESP and a #3 Zacks Rank (read more: Will segmental performance hurt L3Harris Q2 earnings?)

L3Harris Technologies Inc Award and EPS Surprise

L3Harris Technologies Inc price-eps-surprise | L3Harris Technologies Inc Submission

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

Why haven’t you watched Zacks best action?

Our top 5 performing strategies swept away the S&P’s impressive +28.8% gain in 2021. Surprisingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections at no cost or obligation.

See Free Stocks >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

Northrop Grumman Corporation (NOC): Free Stock Analysis Report

Textron Inc. (TXT): Free Stock Analysis Report

L3Harris Technologies Inc (LHX): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.